Shares of Scancell Holdings plc (LON:SCLP – Get Free Report) crossed below its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 13.76 ($0.17) and traded as low as GBX 9.50 ($0.12). Scancell shares last traded at GBX 10.10 ($0.12), with a volume of 844,442 shares.
Scancell Trading Up 3.6 %
The company has a quick ratio of 13.01, a current ratio of 3.42 and a debt-to-equity ratio of 61.41. The firm’s fifty day moving average is GBX 12.30 and its two-hundred day moving average is GBX 13.76. The firm has a market cap of £93.89 million, a P/E ratio of -1,010.00 and a beta of 0.35.
Scancell Company Profile
Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel immunotherapies and vaccines for the treatment of cancer and infectious disease. Its product candidates include SCIB1, an ImmunoBody cancer vaccine that is in Phase II for the treatment of metastatic melanoma; and SCIB2/iSCIB2 vaccine, which is under evaluation for the treatment of patients with solid tumors, including non-small cell lung cancer.
Recommended Stories
- Five stocks we like better than Scancell
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- EV Stocks and How to Profit from Them
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for Scancell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scancell and related companies with MarketBeat.com's FREE daily email newsletter.
